Recursion Pharmaceuticals, Inc.RXRXNASDAQ
LOADING
|||
Analyst Sentiment
Analysts are neutral — opinion is divided on direction.
Consensus Rating
Hold
10 analysts·Moderate coverage
40%
Rating Distribution
Strong Buy
00%
Buy
440%
Hold
660%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Analysts see significant upside — consensus target 172% higher.
Bear Case
$11.00
+172%
Consensus
$11.00
+172%
Bull Case
$11.00
+172%
Price Range10 analysts
Low
Consensus
High
$11.00
$11.00
Current Target
Current Price
$4.05
Upside to Target
$6.95
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.